Medicare enrollees, however, still won’t be able to access the drugs for obesity under a federal law that prohibits the program from paying for weight loss treatments. Right now, Medicare will only ...

Ozempic, Wegovy or Mounjaro? The battle of the weight-loss injections - As drugs emerge as vital to the Government’s ...

Cosmetic products are things like makeup, skin care, hair care, toiletries and perfume. Why are some people worried about cosmetics and cancer? The safety of cosmetic products is a hot topic in the ...

Stanford researchers developed an AI algorithm that identifies Type 2 diabetes subtypes using continuous glucose monitor data, enhancing personalized treatment.

Since Zepbound was approved by the FDA to treat obesity in late 2023, its maker Eli Lilly has been steadily closing in on fierce rival Novo Nordisk’s early lead in the obesity market.

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for ... [+] health insurers, employers and government health programs who cover it in 2025.

Like LVMH, automakers such as Stellantis NV were weighed down by China worries, while obesity-drug hype started to fade, evidenced by Novo Nordisk A/S surrendering a more than 40% gain in the first ...

Getty And the propensity towards obesity is happening on a molecular level, as Professor Ferdinand von Meyenn, a senior author on the study at the Federal Institute of Technology in Zurich ...